Published: 2018-11-28 08:30:00 CET
Nasdaq Nordic

Nasdaq Stockholm Welcomes S2Medical to First North

Stockholm, November 28, 2018— Nasdaq (Nasdaq: NDAQ) announces that the trading in S2Medical AB’s shares (short name: S2M) will commence today on Nasdaq First North in Stockholm. S2Medical belongs to the health care sector and is the 71st company to be admitted to trading on Nasdaq’s Nordic markets* in 2018.

S2Medical is a medical technology company with a vision to make the best medical products available regardless of culture, religion or economy. S2Medical has developed several unique wound healing products and has many disruptive technologies in the pipeline. Its first line of products is based on the material Eiratex® and is striving to be the best tissue protection ever seen. S2Medical is headquartered in Linköping, Sweden. For more information, please visit www.s2m.se.

“We are please to join Nasdaq First North and thereby also taking an important step along our clear and ambitious path to revolutionize wound care with wound healing,” said Petter Sivlér, CEO and co-founder of S2Medical.

”We welcome S2Medical to our European growth market, Nasdaq First North,” said Adam Kostyál, SVP and Head of European Listings, Nasdaq. “S2Medical operates in an exciting and promising field, and we look forward to supporting the entire team on its continued journey in the public market.”

S2Medical AB has appointed Partner Fondkommission AB as the Certified Adviser.

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.

 

About Nasdaq First North

Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 100 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to over 4,000 total listings with a market value of approximately $15 trillion. To learn more, visit business.nasdaq.com.

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Media Relations Contact:
Erik Granström
+46 8 405 78 07
erik.granstrom@nasdaq.com